Get started
Author

Stefania Kinspergher

Observed names: Kinspergher, Stefania, S. Kinspergher
ORCID: 0000-0003-2183-8892
Observed ORCID: 0000-0003-2183-8892
OpenAlex ID: A5081351883
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib ofEGFRmutant advanced lung adenocarcinoma
2015 · Emilio Bria, Sara Pilotto, et al. · Oncotarget · 75
PDF
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
2024 · Brigida Anna Maiorano, Massimo Di Maio, et al. · JAMA Network Open · 61
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung
2014 · Anna Caliò, Alessia Nottegar, et al. · Journal of Thoracic Oncology · 57
PDF
Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer
2021 · Alvise Berti, Roberto Bortolotti, et al. · Critical Reviews in Oncology/Hematology · 50
De novo metastatic castration sensitive prostate cancer: State of art and future perspectives
2018 · Claudia Mosillo, Roberto Iacovelli, et al. · Cancer Treatment Reviews · 50
Association among metabolic syndrome, inflammation, and survival in prostate cancer
2018 · Vincenza Conteduca, Orazio Caffo, et al. · Urologic Oncology Seminars and Original Investigations · 36
Nivolumab (NIVO) in combination with stereotactic body radiotherapy (SBRT) in pretreated patients (pts) with metastatic renal cell carcinoma (mRCC): First results of phase II NIVES study.
2020 · Cristina Masini, Cinzia Iotti, et al. · Journal of Clinical Oncology · 34
Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era
2019 · Marcello Tucci, Orazio Caffo, et al. · Cancer Treatment Reviews · 29
PDF
Tubulin inhibitors in non-small cell lung cancer: looking back and forward
2016 · R. Ferrara, S. Pilotto, et al. · Expert Opinion on Pharmacotherapy · 25
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors
2015 · Sara Pilotto, Isabella Sperduti, et al. · Journal of Thoracic Oncology · 25
PDF
Abiraterone Acetate and its Use in the Treatment of Metastatic Prostate Cancer: A Review
2018 · Orazio Caffo, Antonello Veccia, et al. · Future Oncology · 24
Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer
2020 · Orazio Caffo, Donatello Gasparro, et al. · European Journal of Cancer · 23
PDF
Cardiovascular toxicities of systemic treatments of prostate cancer
2017 · Antonello Veccia, Francesca Maines, et al. · Nature Reviews Urology · 22
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial
2021 · Orazio Caffo, Cinzia Ortega, et al. · European Journal of Cancer · 18
Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials
2013 · Sara Pilotto, Massimo Di Maio, et al. · Critical Reviews in Oncology/Hematology · 17
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma
2022 · Sebastiano Buti, Chiara Tommasi, et al. · Anti-Cancer Drugs · 16
Splice variants of androgen receptor and prostate cancer
2016 · Orazio Caffo, Francesca Maines, et al. · Oncology Reviews · 16
Metastatic castration-resistant prostate cancer in very elderly patients: challenges and solutions
2016 · Orazio Caffo, Francesca Maines, et al. · Clinical Interventions in Aging · 15
PDF
Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature
2020 · Antonello Veccia, Stefania Kinspergher, et al. · Anti-Cancer Drugs · 13
Activity and Safety of Metronomic Cyclophosphamide in the Modern Era of Metastatic Castration-Resistant Prostate Cancer
2019 · Orazio Caffo, Gaetano Facchini, et al. · Future Oncology · 13
Prognostic Role of Inflammatory and Nutritional Biomarkers in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors Alone or in Combination with Chemotherapy as First-Line
2024 · Antonello Veccia, Mariachiara Dipasquale, et al. · Cancers · 11
PDF
Impact of KRAS Mutations on Clinical Outcomes of Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer Receiving Anti-PD-1/PD-L1 Therapy
2022 · Antonello Veccia, Mariachiara Dipasquale, et al. · Targeted Oncology · 11
Pretreatment Lung Immune Prognostic Index as a Biomarker in Advanced Non-Small-Cell Lung Cancer Patients Receiving First Line Pembrolizumab
2021 · Antonello Veccia, Vincenzo Sforza, et al. · Immunotherapy · 11
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations
2016 · U. Peretti, R. Ferrara, et al. · Respiratory Research · 11
PDF
Immune Checkpoint Inhibitors for Non-small-cell Lung Cancer: Does that Represent a ‘New Frontier’?
2014 · Sara Pilotto, Stefania Kinspergher, et al. · Anti-Cancer Agents in Medicinal Chemistry · 11
Works count: 68
Citation count: 790
H-index: 16
I10-index: 25
Year
Topic
Type